A model of anticholinergic activity of atypical antipsychotic medications.

Abstract:

BACKGROUND:Atypical antipsychotics clozapine, olanzapine, and quetiapine have significant affinity for the muscarinic receptors in vitro, while aripiprazole, risperidone, and ziprasidone do not. Dissimilarity in binding profiles may contribute to the reported differences in the anticholinergic effects of these antipsychotics. However, it is difficult with the available data to predict the likelihood of anticholinergic effects occurring with various doses of an atypical antipsychotic. METHODS:We developed a model to assess the potential anticholinergic activity (AA) of atypical antipsychotics at therapeutic doses. A radioreceptor assay was used to measure in vitro AA at 6 clinically relevant concentrations of aripiprazole, clozapine, olanzapine, quetiapine, risperidone, and ziprasidone. Using published pharmacokinetic data, in combination with the measured in vitro AA, dose-AA curves were generated. RESULTS:Clozapine, and to a lesser extent olanzapine and quetiapine showed dose-dependent increases in AA. At therapeutic doses, the AA (in pmol/mL of atropine equivalents) was estimated to range from 27-250, 1-15, and 0-5.4 pmol/mL for clozapine, olanzapine, and quetiapine, respectively. Aripiprazole, risperidone, and ziprasidone did not demonstrate AA at any of the concentrations studied. CONCLUSIONS:Therapeutic doses of clozapine, olanzapine, and, to a lesser extent, quetiapine are associated with clinically relevant AA.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Chew ML,Mulsant BH,Pollock BG,Lehman ME,Greenspan A,Kirshner MA,Bies RR,Kapur S,Gharabawi G

doi

10.1016/j.schres.2006.07.011

subject

Has Abstract

pub_date

2006-12-01 00:00:00

pages

63-72

issue

1-3

eissn

0920-9964

issn

1573-2509

pii

S0920-9964(06)00315-X

journal_volume

88

pub_type

杂志文章
  • Inhibitory processing in visuospatial attention in healthy adults and schizophrenic patients.

    abstract::This study assessed visuospatial attention in healthy adults and medicated schizophrenic patients. Participants performed a visual orientation task in which a peripheral cue was followed. at different intervals, by a target presented either at valid or invalid locations. When the long stimulus onset asynchrony (SOA) w...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(99)00044-4

    authors: Fuentes LJ,Boucart M,Alvarez R,Vivas AB,Zimmerman MA

    更新日期:1999-11-09 00:00:00

  • Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?

    abstract::Due to the limitations of analytical techniques and the complicity of schizophrenia, nowadays it is still a challenge to diagnose and stratify schizophrenia patients accurately. Many attempts have been made to identify and validate available biomarkers for schizophrenia from CSF and/or peripheral blood in clinical stu...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.03.009

    authors: Cao T,Li N,Cai H

    更新日期:2020-12-01 00:00:00

  • Increased distractor vulnerability but preserved vigilance in patients with schizophrenia: evidence from a translational Sustained Attention Task.

    abstract:OBJECTIVE:Attentional deficits represent a core cognitive impairment in schizophrenia. The distractor condition Sustained Attention Task (dSAT) has been identified by the Cognitive Neuroscience Treatment to Improve Cognition in Schizophrenia (CNTRICS) initiative as a promising translational task for assessing schizophr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.01.003

    authors: Demeter E,Guthrie SK,Taylor SF,Sarter M,Lustig C

    更新日期:2013-03-01 00:00:00

  • Sex versus gender differences in schizophrenia: The case for normal personality differences.

    abstract::Schizophrenia has generally been viewed as having a unique preschizophrenia personality or destructive to the personality post-onset. This view is reflected in the scarcity of studies of personality in schizophrenia with the exception of schizotypal personality considered by many as an endophenotype of schizophrenia. ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2017.02.015

    authors: Lewine R,Martin M,Hart M

    更新日期:2017-11-01 00:00:00

  • Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort.

    abstract::Little is known about the impact of family history of psychosis on youth from community samples. To fill this gap, we compared youth with a first-degree relative with psychosis spectrum symptoms (i.e. family history of psychosis spectrum symptoms, FHPS) to youth without FHPS in a cross-sectional analysis of the Philad...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.12.021

    authors: Taylor JH,Asabere N,Calkins ME,Moore TM,Tang SX,Xavier RM,Merikangas AK,Wolf DH,Almasy L,Gur RC,Gur RE

    更新日期:2020-02-01 00:00:00

  • Do schizophrenia and affective disorder share susceptibility genes?

    abstract::Schizophrenia and affective disorders are relatively common neuropsychiatric diseases with a complex genetic etiology. A multigenic inheritance with variable influence of unknown environmental factors may be involved. Family studies have demonstrated the existence of both phenotypes in the same kindreds, and in certai...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/s0920-9964(99)00108-5

    authors: Wildenauer DB,Schwab SG,Maier W,Detera-Wadleigh SD

    更新日期:1999-09-29 00:00:00

  • Elevated IgG anti-histone antibodies in a subgroup of medicated schizophrenic patients.

    abstract::A total of 57 schizophrenic patients (of which 17 were first-episode, neuroleptic naive) and 76 healthy controls were screened for anti-histone IgG antibodies using an enzyme immunoassay (ELISA). All patients had significantly higher anti-histone antibody titers than controls (t = 3.1, p less than 0.003). Previously m...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(92)90073-e

    authors: Chengappa KN,Carpenter AB,Yang ZW,Brar JS,Rabin BS,Ganguli R

    更新日期:1992-04-01 00:00:00

  • High functioning individuals with schizophrenia have preserved social perception but not mentalizing abilities.

    abstract::Social perception and mentalizing are fundamental social cognitive abilities that are related to functioning and are impaired in schizophrenia. A novel approach to examine the relationship between social cognition and community functioning is to first functionally categorize individuals with schizophrenia and then eva...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2016.01.029

    authors: Karpouzian TM,Alden EC,Reilly JL,Smith MJ

    更新日期:2016-03-01 00:00:00

  • A pilot study of functional Cognitive Behavioral Therapy (fCBT) for schizophrenia.

    abstract:BACKGROUND:The feasibility and preliminary efficacy of a novel cognitive behavioral treatment for decreasing psychotic symptoms and improving social functioning was evaluated in a pilot study. This represents the first treatment outcome study of CBT for psychosis with a manualized, active comparison condition. METHODS...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.schres.2004.05.002

    authors: Cather C,Penn D,Otto MW,Yovel I,Mueser KT,Goff DC

    更新日期:2005-05-01 00:00:00

  • No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study.

    abstract::A recent family-based association study identified a putative association between variants in the dystrobrevin binding protein 1 (dysbindin) gene (DTNBP1) and schizophrenia. This study used a sample of 270 Irish pedigrees multiply affected with schizophrenia. We attempted to replicate these findings in an independent ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(02)00527-3

    authors: Morris DW,McGhee KA,Schwaiger S,Scully P,Quinn J,Meagher D,Waddington JL,Gill M,Corvin AP

    更新日期:2003-04-01 00:00:00

  • An overview of medical risk factors for childhood psychosis: Implications for research and treatment.

    abstract:OBJECTIVE:Psychotic disorders in childhood and early adolescence often progress to chronic schizophrenia, but in many cases there are diagnosable medical and genetic causes or risk factors. We reviewed our clinical experience and the relevant literature to identify these factors and to define their clinical features, a...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2017.05.011

    authors: Giannitelli M,Consoli A,Raffin M,Jardri R,Levinson DF,Cohen D,Laurent-Levinson C

    更新日期:2018-02-01 00:00:00

  • Is social anhedonia related to emotional responsivity and expressivity? A laboratory study in women.

    abstract::Social anhedonia is an important feature of schizophrenia and it is a promising indicator of schizotypy. Although social anhedonia is defined as an affective construct (less pleasure derived from social encounters), little is known about the emotional responsivity and expressivity of individuals with high levels of so...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2010.06.012

    authors: Leung WW,Couture SM,Blanchard JJ,Lin S,Llerena K

    更新日期:2010-12-01 00:00:00

  • Prediction of functional remission in first-episode psychosis: 12-month follow-up of the randomized-controlled trial on extended early intervention in Hong Kong.

    abstract:BACKGROUND:Functional remission (FR) is an intermediate and necessary step toward recovery, but is understudied in first-episode psychosis (FEP). We aimed to examine the rate and predictors of FR in FEP patients in the context of a randomized-controlled trial (RCT) comparing a 1-year extension of early intervention (Ex...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2016.03.016

    authors: Chang WC,Kwong VW,Chan GH,Jim OT,Lau ES,Hui CL,Chan SK,Lee EH,Chen EY

    更新日期:2016-05-01 00:00:00

  • The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone.

    abstract:BACKGROUND:A definition of clinical remission in schizophrenia has recently been proposed. However, it is also known that neuropsychological (NP) impairments may be better predictors of functional outcomes than clinical symptoms. Understanding the relationship between clinical remission and cognitive improvement may be...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.12.032

    authors: Buckley PF,Harvey PD,Bowie CR,Loebel A

    更新日期:2007-08-01 00:00:00

  • Comparison of neurocognitive domains in patients with schizophrenia with and without co-morbid obsessive compulsive disorder.

    abstract:BACKGROUND:Neurocognitive deficits have been well documented in patients with schizophrenia. Research has shown that a significant proportion of patients with schizophrenia have co-morbid obsessive-compulsive symptoms/disorder (OCS/OCD). However, the impact of OCS/OCD on various neurocognitive domains in patients with ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.05.029

    authors: Sahoo S,Grover S,Nehra R

    更新日期:2018-11-01 00:00:00

  • Prolonged haloperidol and reduced haloperidol plasma concentrations after decanoate withdrawal.

    abstract::Haloperidol and reduced haloperidol plasma concentrations were measured in twelve schizophrenic patients upon cessation of haloperidol decanoate (HLD) treatment. Each patient received HLD 100 mg every 4 weeks for five injections. After the fifth injection, HLD was discontinued. Haloperidol and reduced haloperidol plas...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(93)90007-6

    authors: Chang WH,Lin SK,Juang DJ,Chen LC,Yang CH,Hu WH,Chien CP,Lam YW,Jann MW

    更新日期:1993-03-01 00:00:00

  • Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera.

    abstract:OBJECTIVE:Evidence from epidemiology suggests that low maternal vitamin D may be a risk factor for schizophrenia. METHOD:Based on sera taken during the third trimester, we compared the level of 25 hydroxyvitamin D3 in mothers of individuals with schizophrenia or schizoaffective disorders versus mothers of unaffected c...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(02)00435-8

    authors: McGrath J,Eyles D,Mowry B,Yolken R,Buka S

    更新日期:2003-09-01 00:00:00

  • Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms.

    abstract::Levels of the histamine metabolites, tele-methylhistamine (t-MH) and tele-methylimidazoleacetic acid (t-MIAA), and metabolites of other aminergic transmitters and of norepinephrine were measured in cerebrospinal fluid of 36 inpatients with chronic schizophrenia and eight controls. The mean t-MH level from controls was...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(94)00034-6

    authors: Prell GD,Green JP,Kaufmann CA,Khandelwal JK,Morrishow AM,Kirch DG,Linnoila M,Wyatt RJ

    更新日期:1995-01-01 00:00:00

  • Motor dysfunction as an intermediate phenotype across schizophrenia and other psychotic disorders: Progress and perspectives.

    abstract::Primary motor abnormalities (PMA), as found in patients with schizophrenia, are quantitatively and qualitatively distinct markers of motor system abnormalities. PMA have been often referred to phenomena that are present across schizophrenia-spectrum disorders. A dysfunction of frontoparietal and subcortical networks h...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2017.10.007

    authors: Hirjak D,Kubera KM,Thomann PA,Wolf RC

    更新日期:2018-10-01 00:00:00

  • Insight and symptom change in schizophrenia and other disorders.

    abstract:OBJECTIVE:This study sought to evaluate levels of insight and change in insight in subjects with schizophrenia and other major psychiatric disorders. This study also evaluated the relationship of insight to acute psychopathology. METHOD:One-hundred and eighty-seven subjects consecutively admitted to an acute care psyc...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(99)00215-7

    authors: Weiler MA,Fleisher MH,McArthur-Campbell D

    更新日期:2000-09-29 00:00:00

  • Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis.

    abstract:BACKGROUND:Some studies have suggested that antipsychotic-naïve patients with nonaffective psychosis (NAP) have glucose intolerance. AIMS:To conduct a systematic review and meta-analysis of fasting glucose (FG), two hour values in the oral glucose tolerance test (2HG), fasting insulin concentration (INS), and insulin ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.schres.2016.09.026

    authors: Greenhalgh AM,Gonzalez-Blanco L,Garcia-Rizo C,Fernandez-Egea E,Miller B,Arroyo MB,Kirkpatrick B

    更新日期:2017-01-01 00:00:00

  • Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight.

    abstract:OBJECTIVE:The study was to examine the levels of adiponectin (APN) and other cytokines, and body metabolism in drug naïve, first episode schizophrenia patients with normal weight. METHODS:Ninety-six drug naïve, first episode schizophrenia patients with normal weight (SZ group), 60 healthy individuals with normal weigh...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.07.044

    authors: Song X,Fan X,Song X,Zhang J,Zhang W,Li X,Gao J,Harrington A,Ziedonis D,Lv L

    更新日期:2013-10-01 00:00:00

  • Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population.

    abstract::The serotonin and dopamine neurotransmitter systems are candidate pathways in the development of schizophrenia because of the assumed causal relationship with the observed symptoms as well as effective targeting of the corresponding receptors by antipsychotic drugs. However, genetic association studies have systematic...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2006.09.022

    authors: Domínguez E,Loza MI,Padín F,Gesteira A,Paz E,Páramo M,Brenlla J,Pumar E,Iglesias F,Cibeira A,Castro M,Caruncho H,Carracedo A,Costas J

    更新日期:2007-02-01 00:00:00

  • Increased platelet phospholipase A2 activity in schizophrenia.

    abstract::The intracellular enzyme phospholipase A2 (PLA2) plays an essential role in the breakdown of membrane phospholipids, which regulate the physicochemical properties of the cell membrane. In the brain PLA2 has been reported to influence receptor function and signal transduction. Regarding dopaminergic neurons, data from ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(94)00060-l

    authors: Gattaz WF,Schmitt A,Maras A

    更新日期:1995-07-01 00:00:00

  • Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome.

    abstract:BACKGROUND:The 22q11.2 deletion syndrome (22q11DS) is one of the highest known risk factors for schizophrenia and recent findings have highlighted the clinical relevance of ultra-high risk (UHR) criteria in this population. However, studies in other at-risk populations have shown that the presence of negative symptoms ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.10.014

    authors: Schneider M,Armando M,Schultze-Lutter F,Pontillo M,Vicari S,Debbané M,Eliez S

    更新日期:2019-04-01 00:00:00

  • Longitudinal study of symptoms and cognitive function in chronic schizophrenia.

    abstract::There is conflicting evidence of a relationship between changes in symptoms and cognitive functioning in schizophrenia. This study investigated longitudinal changes in psychopathology and cognitive functioning in chronic schizophrenia utilising three different dimensional models of symptomatology. Sixty-two patients d...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(01)00393-0

    authors: Hughes C,Kumari V,Soni W,Das M,Binneman B,Drozd S,O'Neil S,Mathew V,Sharma T

    更新日期:2003-02-01 00:00:00

  • Outcome after discharge from an early psychosis program.

    abstract::Studies defining the course and outcome of individuals experiencing their first episode (FE) of psychosis generally report an improvement in symptoms and functioning. Today, many FE patients are treated in specialized early psychosis programs. Little is known what happens to these individuals after discharge from thes...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.08.032

    authors: Addington J,Addington D

    更新日期:2008-12-01 00:00:00

  • Seasonal influences on admissions in schizophrenia and affective disorder in Ireland.

    abstract::Although the seasonal patterns of admissions of affective disorder have been extensively studied, less attention has been given to the seasonal admission patterns of schizophrenia. The traditional method of aggregating the data over a study period, rather than analysing by year of admission may obscure potentially rel...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(98)00106-6

    authors: Clarke M,Moran P,Keogh F,Morris M,Kinsella A,Walsh D,Larkin C,O'Callaghan E

    更新日期:1998-11-30 00:00:00

  • Cognitive predictors of symptom change for participants in vocational rehabilitation.

    abstract:BACKGROUND:This study explored the relationship between cognitive impairments and their impact on rate of symptom improvement in a 26 week work therapy program. METHOD:Data were abstracted from the archives of 157 outpatients with SCID confirmed DSM-IV diagnoses of schizophrenia or schizoaffective disorder who partici...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2007.08.010

    authors: Bell MD,Tsang HW,Greig T,Bryson G

    更新日期:2007-11-01 00:00:00

  • Using self-determination theory to understand motivation deficits in schizophrenia: the 'why' of motivated behavior.

    abstract::Self-determination theory (SDT) provides a model for understanding motivation deficits in schizophrenia, and recent research has focused on problems with intrinsic motivation. However, SDT emphasizes that motivated behavior results from three different factors: intrinsic motivators (facilitated by needs for autonomy, ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.04.027

    authors: Gard DE,Sanchez AH,Starr J,Cooper S,Fisher M,Rowlands A,Vinogradov S

    更新日期:2014-07-01 00:00:00